Our Story
Clinical research is essential for healthcare progress, and EmVenio is dedicated to expanding access to clinical trials worldwide.
An Innovative Site Network
EmVenio Research, a PCM Trials Company, provides a scalable network of clinical trial sites strategically located in underrepresented communities to engage a diverse patient demographic. Our extensive global network comprises highly skilled clinicians, leading principal investigators, and cutting-edge research sites, allowing us to deliver high-quality clinical research services that prioritize reducing the burden on patient participation.
A Name
Our story began with a question. How do we remove barriers to clinical trials for patients in need? We developed our entire organization around a sustainable model designed to cultivate community growth by embracing the full potential of clinical trial research. Our company name emerged after building a formula that captures the essence of this commitment.
EmVenio Research has been providing community-based clinical trial sites and services since 2020. We leverage our global site network, skilled clinicians, and experienced leaders to adapt traditional clinical trials protocols to better reach and recruit diverse and underrepresented participants.
In 2020, Matrix Medical Network launched Matrix Clinical Trials to help organizations enhance their clinical trials to reach broad and diverse trial participant populations and improve the participant experience.
In August of 2022 EmVenio Research acquired Matrix Clinical Trials as a stand-alone Clinical Trial Site Network.
in February of 2024, PCM Trials acquired EmVenio Research becoming the largest independent community site network and the most experienced provider of local clinical trial access globally, to deliver research services to participants wherever they are – in their homes, workplaces, and communities.
Our Purpose
Empowering diverse and underrepresented populations to engage with clinical trials through increased accessibility and convenient options to participate.
Our Mission
EmVenio Research is dedicated to improving clinical trial access and participant experience by providing high-quality and convenient support to participants where they live and work. We operate as a proven partner to sponsors/CROs to help reach diverse, underrepresented, high-risk, and hard-to-recruit populations.
Compliance and Participant safety are core tenets by which EmVenio was founded.
EmVenio’s quality and compliance department established employee training, SOPs and processed aligned to ICH and GCP. EmVenio regularly monitors our studies and processes to ensure they align with all local, state, federal, and global laws and regulations. Additionally, the team regularly audits studies and processes, and qualifies outside vendors to support our clinical trial operations. Our research teams are trained according to ICH standards and all applicable regulations. These rigorous standards have enabled EmVenio’s fleet over the past ten years of healthcare and clinical trial delivery, most recently resulting in supporting 5 NDAs over the past few years.